Rifampicin-induced lupus erythematosus

Clinical and Experimental Dermatology

Volumn 26, Issue 3, 2001, Pages 260-262

  Patel, G K ^a   Anstey, A V ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; CLOBETASONE; CYTOCHROME P450; ETHAMBUTOL; ISONIAZID; LIVER ENZYME; PYRAZINAMIDE; RIFAMPICIN;

AGED; ARTHRALGIA; ARTICLE; BACTERIAL INFECTION; CASE REPORT; CHRONIC BRONCHITIS; CLINICAL FEATURE; DRUG BLOOD LEVEL; HUMAN; LABORATORY TEST; LUPUS ERYTHEMATOSUS; MALAISE; MALE; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; RASH; SKIN MANIFESTATION;

AGED; ANTIBIOTICS, ANTITUBERCULAR; DRUG ERUPTIONS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RIFAMPIN;

EID: 0035724727     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2001.00809.x     Document Type: Article

References (15)

1. Toxic epidermal necrolysis due to rifampicin
2. Pemphigus induced by rifampicin
3. Rifampicin-induced immune thrombocytopaenia
4. Exacerbation of pemphigus by rifampicin
5. Rifampicin-induced porphyria cutanea tarda
6. Drug-related lupus
7. Drug induced lupus: Clinical and serological studies
8. Procainamide-induced lupus erythematosus. Clinical and laboratory observations
9. Hydralazine, antinuclear antibodies and the lupus syndrome
10. Skin immunofluorescence studies on lupus erythematosus and other antinuclear antibody-positive diseases
11. Antihistone antibodies in systemic lupus erythematosus
12. Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies
13. Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex disease
14. Dose limiting toxicity of rifabutin in AIDS-related complex: Syndrome of arthralgia/arthritis
15. Rifamycin-induced lupus syndrome